GS
INSM icon

GTS Securities’s Insmed INSM Stock Holding History

GTS Securities’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,991
Closed -$326K – 1618
2026
Q1 		$326K Buy
+1,991
New +$306K 0.01% 1038
2025
Q1 		– Sell
-3,229
Closed -$223K – 1406
2024
Q4 		$223K Buy
+3,229
New +$233K 0.01% 1053
2024
Q3 		– Sell
-4,652
Closed -$343K – 4251
2024
Q2 		$312K Buy
+4,652
New +$180K ﹤0.01% 3089

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

GTS Securities's INSM Position: Q2 2026 in Review

GTS Securities sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,991 shares — an estimated $326K sold.

GTS Securities first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $326K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • GTS Securities reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,991 Insmed shares in Q2 2026, an estimated $326K.
  • GTS Securities first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
  • GTS Securities's Insmed position peaked at $326K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.